Issued Patents All Time
Showing 1–25 of 38 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12396995 | Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use | Maria Soraya Carrancio Anton, Tonia J. Buchholz, Henry Chang, Ellen Filvaroff, Shailaja Kasibhatla +5 more | 2025-08-26 |
| 12178822 | Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dion | Maria Soraya Carrancio Anton, Tonia J. Buchholz, Shailaja Kasibhatla, Rama Krishna Narla, Michael Pourdehnad | 2024-12-31 |
| 12103923 | Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione | Maria Soraya Carrancio Anton, Tonia J. Buchholz, Rama Krishna Narla, Michael Pourdehnad | 2024-10-01 |
| 12029738 | Antiproliferative compounds and methods of use thereof | Matthew D. Alexander, Gerald D. Artman, III, Gordon L. Bray, James Carmichael, Soraya Carrancio +15 more | 2024-07-09 |
| 11945804 | Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Soraya Carrancio, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +5 more | 2024-04-02 |
| 11733233 | Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases | Brian E. Cathers, Philip Chamberlain, Gang Lu | 2023-08-22 |
| 11726080 | Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile | Maria Soraya Carrancio Anton, Joshua Hansen, Courtney G. Havens, Gang Lu, Lilly L. Wong | 2023-08-15 |
| 11666579 | Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione | Maria Soraya Carrancio Anton, Tonia J. Buchholz, Shailaja Kasibhatla, Rama Krishna Narla, Michael Pourdehnad | 2023-06-06 |
| 11628172 | Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione | Preethi Janardhanan, Shailaja Kasibhatla, Michael Pourdehnad | 2023-04-18 |
| 11590117 | Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | Soraya Carrancio, Paul Hollenbach, Kyle MacBeth, Michael Pourdehnad, Irit Rappley +1 more | 2023-02-28 |
| 11583536 | Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use | Maria Soraya Carrancio Anton, Tonia J. Buchholz, Henry Chang, Ellen Filvaroff, Shailaja Kasibhatla +5 more | 2023-02-21 |
| 11460471 | Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies | Ellen Filvaroff, Gang Lu | 2022-10-04 |
| 11419861 | Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases | Philip Chamberlain, Brian E. Cathers | 2022-08-23 |
| 11390617 | Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione | Maria Soraya Carrancio Anton, Tonia J. Buchholz, Rama Krishna Narla, Michael Pourdehnad | 2022-07-19 |
| 11358952 | Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Soraya Carranclo, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +5 more | 2022-06-14 |
| 11241423 | Antiproliferative compounds and methods of use thereof | Brian E. Cathers, Joshua Hansen, Ehab M. Khalil, Kyle MacBeth, Hon-Wah Man +3 more | 2022-02-08 |
| 11185543 | Antiproliferative compounds and methods of use thereof | Matthew D. Alexander, Gerald D. Artman, III, James Carmichael, Brian E. Cathers, Matthew D. Correa +12 more | 2021-11-30 |
| 10969381 | Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile | Joshua Hansen, Courtney G. Havens, Gang Lu, Lilly L. Wong | 2021-04-06 |
| 10830762 | Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases | Brian E. Cathers, Philip Chamberlain, Gang Lu | 2020-11-10 |
| 10668057 | Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases | Philip Chamberlain, Brian E. Cathers | 2020-06-02 |
| 10648983 | Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies | Ellen Filvaroff, Gang Lu | 2020-05-12 |
| 10357489 | Antiproliferative compounds and methods of use thereof | Matthew D. Alexander, Gerald D. Artman, III, James Carmichael, Brian E. Cathers, Matthew D. Correa +12 more | 2019-07-23 |
| 10245258 | Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | Soraya Carrancio, Paul Hollenbach, Kyle MacBeth, Michael Pourdehnad, Irit Rappley +1 more | 2019-04-02 |
| 10092555 | Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases | Philip Chamberlain, Brian E. Cathers | 2018-10-09 |
| 10047151 | Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor | Peter Schafer, Anita Gandhi, Derek Mendy, Thomas O. Daniel | 2018-08-14 |